USPTO serial 87246841
LIFELABS GENETICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 6, 2021
- Examiner
- GARDNER, DAWNA BERYL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with LIFELABS GENETICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,493*
Plus Government fees of $2,275
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Toronto, Ontario, CA
Toronto, Ontario, CA
Toronto, Ontario, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nicholas G. de la Torre
Nicholas G. de la Torre Neal & McDevitt, LLC2801 Lakeside Drive, Suite 201Bannockburn, IL 60015United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemically treated non-medical test strips for calibration of laboratory test equipment and medical diagnostic equipment; diagnostic preparations for medical laboratory use; diagnostic reagents for clinical and medical laboratory use; assays and reagents for use in genetic research; genetic identity tests comprised of reagents for non-medical purposes; reagents for scientific or medical research use; chemical reagents for non-medical purposes | ACTIVE | — |
| 005 | drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids for the presence of lipids, carbohydrates, proteins, enzymes, acids, alcohols, metabolites, vitamins, electrolytes, heavy metals, contaminants, poisons, and toxins; diagnostic, preparations for medical research use; medical diagnostic reagents; diagnostic kits comprised of organic and inorganic medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; biological preparations for detecting genetic predispositions for medical purposes; newborn screenings, namely, genetic identity tests comprised of reagents for medical purposes; newborn screenings, namely, preparations for detecting somatic mutation in genes for medical purposes; newborn screenings, namely, preparations for detecting autoimmune diseases in genes for medical purposes; newborn screenings, namely, preparations for detecting epigenetic disorders in genes for medical purposes; newborn screenings, namely, medical diagnostic test strips for blood analysis; diagnostic biomarker reagents for analysis of genetic sequencing for medical purposes; diagnostic biomarker reagents for analysis of metabolic disorders for medical purposes; diagnostic biomarker reagents for analysis of enzyme deficiency for medical purposes | ACTIVE | — |
| 009 | Aliquotters, namely, manual and robotic devices for use in medical laboratories to accurately dispense liquid volumes of medical patient samples and reagents into separate specimen containers; filters for blood and blood components for laboratory use; laboratory devices implementing nucleic acid extraction, fluorescence in situ hybridization and competitive hybridization to detect genetic sequences; scientific instruments, namely, analyzers for detecting and karyotyping chromosomes; computer software for scientific analysis of genetic sequences; computer software platform for analyzing bioinformatics to interpret results of genetic testing; computer software platforms for use in generating clinical reports for genetic testing; computer communications software for connecting medical practices via the Internet to manage and share patient information relating to genetic testing orders and results; computer programs for managing requests for genetic testing, laboratory processing and laboratory equipment; computer programs for controlling quality of testing and integrity of testing results | ACTIVE | — |
| 035 | data processing services; customer services, namely, responding to customers inquiries for others in the field of medical laboratory services; customer services, namely, responding to customers inquiries for others in the field of medical diagnostic services | ACTIVE | — |
| 038 | providing access to an electronic exchange of medical records across a nationwide health information network to enable physicians to make informed medical recommendations | ACTIVE | — |
| 042 | medical research consulting; design and development of computer hardware and software for genetic testing, genetic sequencing, biochemical analysis, newborn screening and data processing; laboratory research in the fields of biochemistry and medical genetics; laboratory testing of materials; medical laboratory services; blood analysis services; DNA analysis services for scientific research purposes; providing medical research information in the field of patient clinical trials; providing an interactive web site featuring technology that enables users to access, monitor and generate medical information and reports; providing information relating to pharmacology consultancy | ACTIVE | — |
| 044 | consulting services in the field of genetic testing for medical purposes; consulting services in the field of medical testing for diagnostic purposes; consulting services in the field of medical screening of infants for hereditary medical disorders; medical analysis services for diagnostic and medical purposes, namely, medical analysis of, blood, body fluids, extracellular tissue specimens, stool samples, exhaled air, biopsy specimens and autopsy specimens; Medical laboratory testing of blood, body fluids, extracellular tissue specimens, stool samples, exhaled air, biopsy specimens and autopsy specimens all for diagnostic and medical purposes; medical information services, namely, reporting of patient authorized clinical testing results directly to doctors; medical analysis services of patient medical data for the diagnosis of cancer; providing medical information to doctors in the form of reports in the field of a medical diagnosis; providing healthcare information; providing medical information to patients in the field of pharmaceutical treatments; providing information relating to diagnostic properties of pharmaceuticals; providing medical information; providing health information to physicians about surgical instruments | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LIFELABS LP
- Other trademarks owned by LIFELABS LP
- Other trademarks owned by LIFELABS LP
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 038
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named LIFELABS GENETICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 6, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 27, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 27, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 27, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 27, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 6, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 4, 2021 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Mar 4, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 22, 2020 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Nov 22, 2020 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Sep 29, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 4, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 4, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 15, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 26, 2020 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 24, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 18, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 18, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 18, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 14, 2019 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Dec 13, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 13, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 10, 2019 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Nov 27, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 21, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 21, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 18, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 13, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 13, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 13, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 12, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 12, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 12, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 21, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 21, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 26, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 26, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 26, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 27, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 27, 2019 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Mar 27, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 27, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 26, 2019 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Sep 28, 2018 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Sep 28, 2018 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Sep 28, 2018 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Sep 27, 2018 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Sep 27, 2018 | ALIE | ASSIGNED TO LIE | — |
| Mar 7, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 7, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 7, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 14, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 13, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 13, 2018 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Nov 7, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 7, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 7, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 16, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 16, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 16, 2017 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Sep 22, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 22, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 22, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 7, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 7, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 7, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 9, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 9, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 9, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 1, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 2, 2016 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Dec 1, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 26, 2016 | NWAP | NEW APPLICATION ENTERED | — |